Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (81-90 of 290) with videos related to

Pageof 29
Sort By:
The Journal of Infection|October 21, 2006
Progressive multifocal leukoencephalopathy mimicking cerebral vasculitis in systemic granulomatosisBenjamin Terrier, Valérie Martinez, Danielle Seilhean, et al.
AJNR. American Journal of Neuroradiology|July 12, 2024
Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with <i>IDH</i>-Mutant GliomaLucia Nichelli, Capucine Cadin, Patrizia Lazzari, et al.
Journal of Neuro-Oncology|May 29, 2004
Loss of 14q chromosome in oligodendroglial and astrocytic tumorsCharles Dichamp, Sophie Taillibert, Lucinda Aguirre-Cruz, et al.
Biomed Research International|May 31, 2014
IDH mutations: genotype-phenotype correlation and prognostic impactXiao-Wei Wang, Pietro Ciccarino, Marta Rossetto, et al.
Cancer Genetics and Cytogenetics|December 23, 2008
TP53 mutations but no CHEK2 *1100DelC variant in familial gliomasSoufiane El Hallani, Blandine Boisselier, Yannick Marie, et al.
Journal of Neuro-Oncology|May 29, 2004
Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumorsLucinda Aguirre-Cruz, Karima Mokhtari, Khê Hoang-Xuan, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastomaElodie Vauleon, Nathalie Auger, Alexandra Benouaich-Amiel, et al.
Journal of Neuro-Oncology|June 15, 2007
No association of MDM2 SNP309 with risk of glioblastoma and prognosisSoufiane El Hallani, Yannick Marie, Ahmed Idbaih, et al.
European Radiology|March 31, 2021
Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomasArnaud Pellerin, Maya Khalifé, Marc Sanson, et al.
Journal of Neuro-Oncology|January 9, 2010
Up-front temozolomide in elderly patients with glioblastomaFlorence Laigle-Donadey, Dominique Figarella-Branger, Olivier Chinot, et al.
Pageof 29

Showing results (81-90 of 290) with videos related to

Sort By:
Pageof 29
The Journal of Infection|October 21, 2006
Progressive multifocal leukoencephalopathy mimicking cerebral vasculitis in systemic granulomatosisBenjamin Terrier, Valérie Martinez, Danielle Seilhean, et al.
AJNR. American Journal of Neuroradiology|July 12, 2024
Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with <i>IDH</i>-Mutant GliomaLucia Nichelli, Capucine Cadin, Patrizia Lazzari, et al.
Journal of Neuro-Oncology|May 29, 2004
Loss of 14q chromosome in oligodendroglial and astrocytic tumorsCharles Dichamp, Sophie Taillibert, Lucinda Aguirre-Cruz, et al.
Biomed Research International|May 31, 2014
IDH mutations: genotype-phenotype correlation and prognostic impactXiao-Wei Wang, Pietro Ciccarino, Marta Rossetto, et al.
Cancer Genetics and Cytogenetics|December 23, 2008
TP53 mutations but no CHEK2 *1100DelC variant in familial gliomasSoufiane El Hallani, Blandine Boisselier, Yannick Marie, et al.
Journal of Neuro-Oncology|May 29, 2004
Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumorsLucinda Aguirre-Cruz, Karima Mokhtari, Khê Hoang-Xuan, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastomaElodie Vauleon, Nathalie Auger, Alexandra Benouaich-Amiel, et al.
Journal of Neuro-Oncology|June 15, 2007
No association of MDM2 SNP309 with risk of glioblastoma and prognosisSoufiane El Hallani, Yannick Marie, Ahmed Idbaih, et al.
European Radiology|March 31, 2021
Simultaneously acquired PET and ASL imaging biomarkers may be helpful in differentiating progression from pseudo-progression in treated gliomasArnaud Pellerin, Maya Khalifé, Marc Sanson, et al.
Journal of Neuro-Oncology|January 9, 2010
Up-front temozolomide in elderly patients with glioblastomaFlorence Laigle-Donadey, Dominique Figarella-Branger, Olivier Chinot, et al.
Pageof 29